Foresite Capital Management II as of Sept. 30, 2016
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 10 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 30.1 | $63M | 1.7M | 37.74 | |
| Aimmune Therapeutics | 28.4 | $60M | 4.0M | 15.00 | |
| Alder Biopharmaceuticals | 12.6 | $26M | 803k | 32.77 | |
| Universal American | 10.3 | $22M | 2.8M | 7.65 | |
| Epizyme | 7.2 | $15M | 1.5M | 9.84 | |
| Nanostring Technologies (NSTGQ) | 7.2 | $15M | 753k | 19.98 | |
| Nexvet Biopharma Pub Ltd Co ord | 1.8 | $3.7M | 900k | 4.15 | |
| Zafgen | 1.2 | $2.5M | 760k | 3.31 | |
| Orexigen Therapeutics | 0.9 | $1.8M | 543k | 3.32 | |
| BioDelivery Sciences International | 0.3 | $608k | 225k | 2.70 |
